Sally Curley

Sally is CEO of Curley Global IR, LLC, an Investor Relations, Environmental-Social-Governance and Governance Engagement strategic consultancy. In addition to MOBILion’s Advisory Board, Sally serves as a Director of the Ariel Savannah Angel Partners Board and Chairs the Board of Human Health Project. With more than 30 years of business experience, Sally has worked for and represented companies across a number of industries. For nearly a decade, Sally served as Senior Vice President, Investor Relations for Cardinal Health, a Fortune 20 global healthcare services company, where she was a member of the Global Leadership Team and built and led worldwide IR. While there, Sally created and co-chaired the company’s first ESG Committee, formed to identify business-related ESG initiatives and disclosures. Prior to Cardinal Health, Sally was Vice President, Investor Relations for Genzyme Corporation (now Sanofi), where she built and led global IR and advised its Board’s Nominating and Governance Committee on ESG topics. She holds a B.A. from Colby College, an M.B.A. from Northeastern University, and a Certificate of Biotechnical Education from Boston University Medical School.